Pro Share Advisors LLC Magenta Therapeutics, Inc. Transaction History

Pro Share Advisors LLC

  • $39.7 Billion
  • Q3 2024

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 01, 2022
SELL
$0.97 - $3.08 $11,340 - $36,008
-11,691 Closed
0 $0
Q1 2022

May 10, 2022
SELL
$2.55 - $5.23 $7,958 - $16,322
-3,121 Reduced 21.07%
11,691 $34,000
Q4 2021

Feb 08, 2022
SELL
$4.43 - $8.33 $6,786 - $12,761
-1,532 Reduced 9.37%
14,812 $67,000
Q3 2021

Nov 12, 2021
SELL
$6.07 - $9.89 $11,393 - $18,563
-1,877 Reduced 10.3%
16,344 $119,000
Q2 2021

Aug 13, 2021
BUY
$9.76 - $14.15 $58,628 - $84,999
6,007 Added 49.18%
18,221 $178,000
Q1 2021

May 14, 2021
BUY
$7.66 - $13.38 $1,332 - $2,328
174 Added 1.45%
12,214 $145,000
Q4 2020

Feb 09, 2021
BUY
$6.1 - $7.94 $10,546 - $13,728
1,729 Added 16.77%
12,040 $94,000
Q3 2020

Nov 13, 2020
BUY
$6.52 - $8.94 $67,227 - $92,180
10,311 New
10,311 $70,000
Q1 2020

May 15, 2020
SELL
$6.03 - $15.24 $66,547 - $168,188
-11,036 Closed
0 $0
Q4 2019

Feb 12, 2020
SELL
$9.07 - $15.84 $14,920 - $26,056
-1,645 Reduced 12.97%
11,036 $167,000
Q3 2019

Nov 12, 2019
SELL
$9.63 - $14.0 $905 - $1,316
-94 Reduced 0.74%
12,681 $130,000
Q2 2019

Aug 13, 2019
SELL
$13.4 - $17.67 $750 - $989
-56 Reduced 0.44%
12,775 $188,000
Q1 2019

May 15, 2019
BUY
$5.7 - $19.7 $6,765 - $23,383
1,187 Added 10.19%
12,831 $211,000
Q4 2018

Feb 14, 2019
BUY
$5.57 - $11.65 $64,857 - $135,652
11,644 New
11,644 $66,000

Others Institutions Holding MGTA

# of Institutions
2
Shares Held
442K
Call Options Held
0
Put Options Held
0
View Full List

About Magenta Therapeutics, Inc.

MGTA Quotes by TradingView
  • Ticker MGTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,890,500
  • Description
  • Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...
More about MGTA
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email